Displaying items by tag: uab medicine

A drug long used for adults with sickle cell disease could change how the disease is managed in very young children.

Mom celebrates Mother’s Day knowing she gave teen son gift of life twice.

UAB geriatrician Andrew Duxbury has written a play for a senior adult theatre troupe with some important messages for older Americans.

Trauma patients throughout state transported to UAB for treatment; more expected.

Caring for storm victims’ psychological wounds important too, says UAB psychologist.

UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.

For about $200 per child, the seven-day mortality rate for newborns in Zambia dropped by 40 percent.

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Adding cystatin C to a diagnostic panel revealed one person in six who had chronic kidney disease that was undetected using the conventional test.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers